TOWARD PERSONALIZED MEDICINE IN THE NEUROPSYCHIATRIC FIELD

被引：12
|
作者：
Wong, Erik H. F. [1 ]
Fox, Jayne C. [2 ]
Ng, Mandy Y. M. [2 ]
Lee, Chi-Ming [3 ]
机构：
[1] AstraZeneca, External Sci, CNS Pain Innovat Med Unit, Wilmington, DC USA
[2] AstraZeneca, Personalized Hlth Care & Biomarkers, Macclesfield, Cheshire, England
[3] AstraZeneca, Discovery Enabling Capabil & Sci, Macclesfield, Cheshire, England
来源：
BIOMARKERS OF NEUROLOGICAL AND PSYCHIATRIC DISEASE | 2011年 / 101卷
关键词：
STAR-ASTERISK-D; GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; MAJOR DEPRESSION; INTERMEDIATE PHENOTYPES; MELANCHOLIC FEATURES; MISMATCH NEGATIVITY; MISSENSE MUTATIONS; TREATMENT RESPONSE; DRUG DISCOVERY;
D O I：
10.1016/B978-0-12-387718-5.00013-4
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
There are great expectations for the personalized medicine approach to address the therapeutic needs of patients in the twenty-first century Advances in human genome science and molecular innovations in neuroscience have encouraged the pharmaceutical industry to focus beyond broad spectrum population therapeutics-the driving force behind the "blockbuster" product concept-to personalized medicine. For central nervous system (CNS) therapeutics, repeated failures in converting scientific discoveries to clinical trial successes and regulatory approvals have precipitated a drug pipeline crisis and eroded confidence in the industry This chapter describes how innovations in genomics and translational medicine can impact the future of neuropsychiatry and deconvolute the complexity of psychiatric diseases from symptoms biology A targeted and consistent investment is needed to restore confidence in translating science into clinical success.
引用
收藏
页码：329 / 349
页数：21
相关论文
共 50 条
  • [1] Toward Personalized Medicine in Bronchiolitis
    Alvarez Paggi, Damian
    Polack, Fernando P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : 1456 - 1458
  • [2] Metabolomics toward personalized medicine
    Jacob, Minnie
    Lopata, Andreas L.
    Dasouki, Majed
    Rahman, Anas M. Abdel
    MASS SPECTROMETRY REVIEWS, 2019, 38 (03) : 221 - 238
  • [3] Toward Exercise as Personalized Medicine
    Thomas W. Buford
    Michael D. Roberts
    Timothy S. Church
    Sports Medicine, 2013, 43 : 157 - 165
  • [4] Toward Exercise as Personalized Medicine
    Buford, Thomas W.
    Roberts, Michael D.
    Church, Timothy S.
    SPORTS MEDICINE, 2013, 43 (03) : 157 - 165
  • [5] Toward Precision Medicine for Neurological and Neuropsychiatric Disorders
    Gibbs, Rebecca M.
    Lipnick, Scott
    Bateman, Joel W.
    Chen, Lloyd
    Cousins, Henry C.
    Hubbard, Elizabeth G.
    Jowett, Geraldine
    LaPointe, Darren S.
    McGredy, Maxine J.
    Odonkor, Michelle N.
    Repetti, Giuliana
    Thomas, Elizabeth
    Rubin, Lee L.
    CELL STEM CELL, 2018, 23 (01) : 21 - 24
  • [6] Toward personalized medicine for cardiovascular pharmacotherapy
    Tamargo, Juan
    Hasegawa, Koji
    Agewall, Stefan
    EUROPEAN HEART JOURNAL, 2022, 43 (45) : 4719 - 4721
  • [7] Progress toward personalized medicine for glaucoma
    Moroi, Sayoko E.
    Raoof, Duna A.
    Reed, David M.
    Zoellner, Sebastian
    Qin, Zhaohui
    Richards, Julia E.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (02) : 145 - 161
  • [8] Skipping toward personalized molecular medicine
    Hoffman, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26): : 2719 - 2722
  • [9] Toward Personalized Medicine in Renal Transplantation
    Lampreabe, I.
    Gainza de Los Rios, F. J.
    Arrieta Gutierrez, A.
    Jofre-Monseny, L.
    Rodriguez, M.
    Amenabar Iribar, J. J.
    Zarraga Larrondo, S.
    Tejedor, D.
    Martinez, A.
    Olano-Martin, E.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 2864 - 2867
  • [10] From bioinformatics toward personalized medicine
    Fukuoka Y.
    Transactions of Japanese Society for Medical and Biological Engineering, 2019, 57 (4-5): : 99 - 104
12345